EP1208212A4 - Fibrin sealant as a transfection/transformation vehicle for gene therapy - Google Patents

Fibrin sealant as a transfection/transformation vehicle for gene therapy

Info

Publication number: EP1208212A4
Authority: EP; European Patent Office
Prior art keywords: transfection; gene therapy; fibrin sealant; transformation vehicle; transformation
Prior art date: 1999-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99935322A

Other languages

German (de)

French (fr)

Other versions

EP1208212A1 (en

Inventor

Stewart A Cederholm-Williams

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

VIVOLUTION AS

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

1999-06-16

Publication date

2007-05-02

1999-06-16 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2002-05-29 Publication of EP1208212A1 publication Critical patent/EP1208212A1/en

2007-05-02 Publication of EP1208212A4 publication Critical patent/EP1208212A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

EP99935322A 1999-06-16 1999-06-16 Fibrin sealant as a transfection/transformation vehicle for gene therapy Withdrawn EP1208212A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1999/013508 WO2000077227A1 (en)	1999-06-16	1999-06-16	Fibrin sealant as a transfection/transformation vehicle for gene therapy

Publications (2)

Publication Number	Publication Date
EP1208212A1 EP1208212A1 (en)	2002-05-29
EP1208212A4 true EP1208212A4 (en)	2007-05-02

Family

ID=22272977

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99935322A Withdrawn EP1208212A4 (en)	1999-06-16	1999-06-16	Fibrin sealant as a transfection/transformation vehicle for gene therapy

Country Status (4)

Country	Link
EP (1)	EP1208212A4 (en)
JP (1)	JP2003502047A (en)
CA (1)	CA2375346A1 (en)
WO (1)	WO2000077227A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0423681D0 (en) *	2004-10-26	2004-11-24	Sec Dep For Environment Food &	Vaccine and nucleic acids
MX2011000281A (en)	2008-07-09	2011-04-26	Profibrix Bv	Recombinant fibrinogen.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995024929A2 (en) *	1994-03-15	1995-09-21	Brown University Research Foundation	Polymeric gene delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5626863A (en) *	1992-02-28	1997-05-06	Board Of Regents, The University Of Texas System	Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
CN1091315A (en) *	1992-10-08	1994-08-31	E·R·斯奎布父子公司	Fibrin sealant compositions and using method thereof
US5833651A (en) *	1996-11-08	1998-11-10	Medtronic, Inc.	Therapeutic intraluminal stents

1999
- 1999-06-16 CA CA002375346A patent/CA2375346A1/en not_active Abandoned
- 1999-06-16 JP JP2001503669A patent/JP2003502047A/en active Pending
- 1999-06-16 WO PCT/US1999/013508 patent/WO2000077227A1/en active Application Filing
- 1999-06-16 EP EP99935322A patent/EP1208212A4/en not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995024929A2 (en) *	1994-03-15	1995-09-21	Brown University Research Foundation	Polymeric gene delivery system

Also Published As

Publication number	Publication date
EP1208212A1 (en)	2002-05-29
CA2375346A1 (en)	2000-12-21
JP2003502047A (en)	2003-01-21
WO2000077227A1 (en)	2000-12-21

Legal Events

Date	Code	Title	Description
2002-04-12	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-05-29	17P	Request for examination filed	Effective date: 20020109
2002-05-29	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2007-05-02	A4	Supplementary search report drawn up and despatched	Effective date: 20070314
2007-05-02	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 48/00 20060101AFI20070308BHEP
2007-08-15	17Q	First examination report despatched	Effective date: 20070716
2008-08-13	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: VIVOLUTION A/S
2008-08-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-09-24	18D	Application deemed to be withdrawn	Effective date: 20080327

Publication	Publication Date	Title
IL143401A0 (en)	2002-04-21	Self-propelled drive wheel
AU7578600A (en)	2001-04-17	Multi-dose syringe driver
AU2002348163A1 (en)	2003-05-19	Therapeutic methods for nucleic acid delivery vehicles
EP1132251A4 (en)	2011-08-31	Hybrid drive system
AU4595300A (en)	2000-12-05	Reactions using lewis acids
AUPP805599A0 (en)	1999-02-04	A direct smelting process
AUPQ008799A0 (en)	1999-05-27	Genome sequencing
AU1335201A (en)	2001-07-16	Hydrodesulfurization process
EP1175228A4 (en)	2003-02-26	Gene therapy using tgf-beta
AU6288599A (en)	2001-05-10	Fibrin sealant applicator system
AU3583000A (en)	2000-08-18	Method for direct steelmaking
EP1208212A4 (en)	2007-05-02	Fibrin sealant as a transfection/transformation vehicle for gene therapy
AU2732000A (en)	2000-08-01	Reverse gene therapy
EP1144631A3 (en)	2002-01-30	Insulin-synthesis genes
IL143400A0 (en)	2002-04-21	Self-propelled drive wheel
AU1151501A (en)	2001-05-14	Stud for tire
AU4708501A (en)	2001-06-25	Hybrid digital-analog controller
IL143398A0 (en)	2002-04-21	Self-propelled drive wheel
GB9924981D0 (en)	1999-12-22	Gene therapy
AU1284500A (en)	2000-06-13	A driver primarily for posts
GB9900009D0 (en)	1999-02-24	Gene therapy
AU5088600A (en)	2000-12-28	Gene therapy products
AU6843400A (en)	2001-03-26	Jack for vehicles
AU6871900A (en)	2001-04-10	Tsg-like gene
GB0406539D0 (en)	2004-04-28	Gene therapy